Literature DB >> 2570752

Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12.

B A McCormick1, D P Franklin, D C Laux, P S Cohen.   

Abstract

Escherichia coli F-18, an excellent colonizer of the streptomycin-treated mouse large intestine, produces type 1 pili. E. coli F-18 FimA-, type 1 pilus negative, and E. coli F-18 FimH-, type 1 pilus positive but adhesin negative, were constructed by bacteriophage P1 transduction of defective fimA and fimH genes from the E. coli K-12 strains ORN151 and ORN133, respectively, into E. coli F-18. Adhesion of E. coli F-18 to an immobilized mannose-bovine serum albumin glycoconjugate was about sixfold greater than that of either E. coli F-18 FimA- or E. coli F-18 FimH-, and adhesion of E. coli F-18 to immobilized cecal epithelial cell brush border membranes was between two- and threefold greater than that of E. coli F-18 FimA- or E. coli F-18 FimH-. When either E. coli F-18 FimA- or E. coli FimH- was fed to streptomycin-treated mice together with E. coli F-18, the pilus-negative and adhesin-negative strains colonized as well as their type 1-piliated parent. Essentially the same result was observed when the type 1-piliated E. coli K-12 strain ORN152 was fed to streptomycin-treated mice together with a nearly isogenic K-12 FimA- strain, ORN151. Furthermore, when streptomycin-treated mice were fed E. coli F-18 FimA- or E. coli F-18 FimH- together with E. coli F-18 Col-, which also makes type 1 pili but is a poor colonizer relative to E. coli F-18 because it grows poorly in mucus in the presence of E. coli F-18, the F-18 FimA- and F-18 FimH- strains colonized well (10(6) to 10(7) CFU/g of feces), whereas the number of E. coli F-18 Col- in feces decreased rapidly to 10(2) CFU/g of feces. These data show that in streptomycin-treated mice, the inability to produce functional type 1 pili has no effect on the ability of E. coli F-18 and E. coli K-12 to colonize the large intestine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570752      PMCID: PMC260765          DOI: 10.1128/iai.57.10.3022-3029.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors.

Authors:  I Ofek; D Mirelman; N Sharon
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

2.  Direct selection for P1-sensitive mutants of enteric bacteria.

Authors:  R B Goldberg; R A Bender; S L Streicher
Journal:  J Bacteriol       Date:  1974-06       Impact factor: 3.490

3.  Colonization resistance of the digestive tract of mice during systemic antibiotic treatment.

Authors:  D van der Waaij; J M Berghuis; J E Lekkerkerk
Journal:  J Hyg (Lond)       Date:  1972-12

4.  Further observations on Escherichia coli enterotoxins with particular regard to those produced by atypical piglet strains and by calf and lamb strains: the transmissible nature of these enterotoxins and of a K antigen possessed by calf and lamb strains.

Authors:  H W Smith; M A Linggood
Journal:  J Med Microbiol       Date:  1972-05       Impact factor: 2.472

5.  Investigation of minor components of Escherichia coli type 1 fimbriae: protein chemical and immunological aspects.

Authors:  K A Krogfelt; P Klemm
Journal:  Microb Pathog       Date:  1988-03       Impact factor: 3.738

6.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

7.  Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside.

Authors:  M Aronson; O Medalia; L Schori; D Mirelman; N Sharon; I Ofek
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

8.  Episome-carried surface antigen K88 of Escherichia coli. I. Transmission of the determinant of the K88 antigen and influence on the transfer of chromosomal markers.

Authors:  I Orskov; F Orskov
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

9.  Comparison of Escherichia coli fimbrial antigen F7 with type 1 fimbriae.

Authors:  I Orskov; F Orskov; A Birch-Andersen
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

10.  Effect of piliation on Klebsiella pneumoniae infection in rat bladders.

Authors:  R C Fader; C P Davis
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

View more
  31 in total

1.  Adhesion of type 1-fimbriated Escherichia coli to abiotic surfaces leads to altered composition of outer membrane proteins.

Authors:  K Otto; J Norbeck; T Larsson; K A Karlsson; M Hermansson
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  Type 1 fimbriation and its phase switching in diarrheagenic Escherichia coli strains.

Authors:  K Iida; Y Mizunoe; S N Wai; S Yoshida
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

3.  Impaired colonization by and full invasiveness of Escherichia coli K1 bearing a site-directed mutation in the type 1 pilin gene.

Authors:  C A Bloch; P E Orndorff
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

Review 4.  What's for dinner?: Entner-Doudoroff metabolism in Escherichia coli.

Authors:  N Peekhaus; T Conway
Journal:  J Bacteriol       Date:  1998-07       Impact factor: 3.490

Review 5.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

6.  Analysis of Shigella flexneri Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts.

Authors:  Kourtney P Nickerson; Rachael B Chanin; Jeticia R Sistrunk; David A Rasko; Peter J Fink; Eileen M Barry; James P Nataro; Christina S Faherty
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

7.  The streptomycin-treated mouse intestine selects Escherichia coli envZ missense mutants that interact with dense and diverse intestinal microbiota.

Authors:  Mary P Leatham-Jensen; Jakob Frimodt-Møller; Jimmy Adediran; Matthew E Mokszycki; Megan E Banner; Joyce E Caughron; Karen A Krogfelt; Tyrrell Conway; Paul S Cohen
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

Review 8.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

9.  Lesions in two Escherichia coli type 1 pilus genes alter pilus number and length without affecting receptor binding.

Authors:  P W Russell; P E Orndorff
Journal:  J Bacteriol       Date:  1992-09       Impact factor: 3.490

10.  Utilization of the mouse large intestine to select an Escherichia coli F-18 DNA sequence that enhances colonizing ability and stimulates synthesis of type 1 fimbriae.

Authors:  R L Burghoff; L Pallesen; K A Krogfelt; J V Newman; M Richardson; J L Bliss; D C Laux; P S Cohen
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.